Meeting
2017 Gastrointestinal Cancers Symposium
Association of adjuvant chemotherapy with improved overall survival for patients with locally advanced rectal cancer (LARC) who achieve a pathologic complete response (pCR) to neoadjuvant chemoradiation (nCRT).
Authors
Danish Shahab
University at Buffalo, Department of Medicine, Buffalo, NY
Danish Shahab , Emmanuel M. Gabriel , Kristopher Attwood , Valerie Francescutti , Wen Wee Ma , Steven J. Nurkin , Patrick McKay Boland
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 716)
DOI
10.1200/JCO.2017.35.4_suppl.716
Abstract #
716
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Effect of adjuvant chemotherapy following pathologic complete response on long-term survival in rectal cancer: A propensity score matched analysis.
First Author: Ali Mokdad
Poster
2021 ASCO Annual Meeting
Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).
First Author: Weiwei Xiao
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2017 Gastrointestinal Cancers Symposium
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
First Author: Shaan Dudani